Peptide Nomenclature: IUPAC Rules and BPC-157 Example for Researchers

Peptide nomenclature follows the IUPAC/JCBN rules: write sequences from the N-terminus to the C-terminus, then either use one-letter or three-letter amino-acid symbols for shorthand notation, or construct a full systematic name by converting every nonterminal residue into its acyl “-yl” form. These recommendations, laid out in IUPAC’s Nomenclature and Symbolism for Amino Acids and Peptides, remain the governing standard for how chemists name peptides in papers, databases, and lab notebooks.

TL;DR:

• Peptides should be named with sequences written from N-terminus to C-terminus, using either three-letter or one-letter amino acid codes, with terminal markers if ionization states are relevant.
• Converting nonterminal residues to acyl “-yl” forms is essential for creating systematic IUPAC names, while the final residue remains in its original form.
• Pairing the peptide sequence with a persistent database identifier, such as a PubChem CID, ensures precise identification and avoids ambiguity, especially for research and regulatory purposes.
• Cyclic peptides require special notation, including prefixes like “cyclo” and residue numbers, as they lack free termini, making standard linear naming conventions insufficient.
• Proper numbering starts at residue 1 at the N-terminus, with atom locants combined with residue numbers to unambiguously specify modifications or labels at specific sites.

Table of Contents

• Understanding Amino Acid One Letter Codes and Three-Letter Symbols
• Building a Systematic IUPAC Peptide Name
• Semitrivial Names: Shorthand for Peptide Variants
• Cyclic and Bridged Peptides Need Their Own Notation
• Numbering Residues and Atoms for Precise Localization
• A Worked Example: Naming BPC-157 Correctly
• Quick Reference: Do’s, Don’ts, and Common Mistakes
• Why Precise Peptide Naming Matters: A Mycelia Link Perspective
• Sources
• FAQ

Understanding Amino Acid One Letter Codes and Three-Letter Symbols

Every amino acid carries two official symbols: a three-letter abbreviation (initial capital, two lowercase letters) and a single capital letter. Alanine is Ala or A. Glycine is Gly or G. Lysine is Lys or K. The three-letter form reads more like English and shows up in older papers and textbooks; the one-letter form is the standard for sequence databases, alignment tools, and anywhere space matters.

A handful of symbols carry extra meaning. B (Asx) and Z (Glx) signal uncertainty between two related residues, aspartate/asparagine and glutamate/glutamine, common in older mass spec data. X (Xaa) marks a residue that’s simply unknown or unspecified. U (Sec) covers selenocysteine, the 21st amino acid. Capitalization is not decorative; a lowercase letter in a sequence string traditionally flags a D-amino acid rather than the standard L-form.

• Hyphens connect three-letter residues in sequence (Gly-Glu-Pro) and separate terminal groups from the chain.
• One-letter strings run together with no punctuation (GEPPPGKPADDAGLV).
• A terminal H- or -OH marker, when included, shows the free amino or carboxyl end explicitly.

Full details on capitalization and the ambiguity codes sit in IUPAC’s one-letter and three-letter symbol tables.

Building a Systematic IUPAC Peptide Name

Sequence symbols like GEPPPGKPADDAGLV are shorthand. A systematic chemical name is a different animal entirely, and building one correctly follows three steps.

1. Confirm direction. Every constructed name reads N-terminus to C-terminus, no exceptions. Get this backward and the whole name describes a different molecule.
2. Convert nonterminal residues to acyl “-yl” form. Each residue except the last one loses its free carboxyl group to a new amide bond, and its name shifts accordingly: glycine becomes glycyl, alanine becomes alanyl, leucine becomes leucyl.
3. End with the intact C-terminal residue name. The final residue keeps its free acid form and its ordinary name, unmodified.

Glycylalanine is the two-residue result of Gly-Ala. A tripeptide like Fly-Ala-Ser becomes glycylalanylserine. Stack enough residues together and the name gets long fast, which is exactly why database identifiers and one-letter strings exist alongside constructed names rather than instead of them.

Configuration matters too. Standard biological amino acids are L-form by default, so D-configured residues need an explicit D- prefix (Daphne, not Phe) or the name misrepresents the molecule’s actual stereochemistry.

Pro Tip: When ionization state matters for synthesis or activity, add the terminal notation explicitly: H- for a free amino terminus, -OH for a free carboxyl, or -O- for a deprotonated carboxylate. Skipping these on a modified or charged peptide is one of the most common ambiguity errors in manuscript submissions.

Semitrivial Names: Shorthand for Peptide Variants

Full systematic names get unwieldy fast, so IUPAC allows semitrivial shorthand for peptides that already carry an established trivial name, like oxytocin or a known research peptide.

• Bracketed replacement shows a substituted residue at a specific position: [Phe4]Oxytocin means position 4 in oxytocin’s sequence has been swapped for phenylalanine.
• Removal (des-) indicates a deleted residue: des-Gly-oxytocin drops the terminal glycine.
• Insertion (endo-) flags an added residue within an existing chain rather than at either end.
• Reversal (retro-) signals the sequence has been run backward relative to the parent peptide.

Semitrivial naming works fine for internal lab notes, informal literature references, and quick comparisons between analogs. It falls short the moment a name needs to go into a regulatory filing, a patent claim, or a synthesis protocol, where only a full constructed name or a database identifier removes all ambiguity.

Cyclic and Bridged Peptides Need Their Own Notation

Cyclic peptides break the simple N-to-C convention because there’s no free terminus to anchor the name. IUPAC’s 2004 recommendations split these into two categories: homodetic cycles, where the ring closes through ordinary peptide bonds only, and heterodetic cycles, where a disulfide bridge, ester, or other linkage closes the ring instead.

• The prefix cyclo precedes a homodetic ring name, written as cyclo(-Val-Orn-Leu-…-).
• Anhydro and epoxy prefixes mark specific bridging chemistries in heterodetic structures, such as ether or ester closures.
• Residue numbers and atom locants are cited before the prefix whenever the ring closure needs pinpointing to a specific position.
• Cyclization often generates new stereocenters, so the name must state the resulting configuration rather than assume it.

A linear sequence written in a circle is not, by itself, a valid cyclic name. The closure chemistry has to appear explicitly, or the name describes an ambiguous structure that a chemist can’t reliably synthesize from the label alone.

Numbering Residues and Atoms for Precise Localization

Residues are numbered starting at 1 from the N-terminus and counting up toward the C-terminus. That numbering becomes essential the moment a paper needs to localize a modification, an isotopic label, or a substitution to one specific spot in the chain.

Atom locants combine with residue numbers in the format atom.residue. A carbon modification at residue 5 might read C-3.5, meaning atom 3 of residue 5. This combined system shows up in names like N5.4-methyloxytocin, which places a methyl group on the nitrogen (N) of atom position 4 within residue 5.

1. Number every residue from the N-terminus (residue 1) to the C-terminus.
2. Identify the specific atom within a residue that carries the modification.
3. Combine them as atom.residue to create an unambiguous locant.

Skipping this step is a common reason peer reviewers send papers back. A database curator or a lab trying to replicate a synthesis needs the exact locant, not a general description of “a methylated variant.”

A Worked Example: Naming BPC-157 Correctly

BPC-157 makes a useful teaching case because every notation style applies to it cleanly. PubChem lists the sequence as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a 15-residue chain running N-terminus to C-terminus.

• Three-letter form: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
• One-letter form: GEPPPGKPADDAGLV
• Terminal-explicit form: H-GEPPPGKPADDAGLV-OH, showing the free amino and carboxyl termini
• Database identifier: PubChem CID 9941957

Why this matters: A compact one-letter string like GEPPPGKPADDAGLV is fast to scan but says nothing about termini, stereochemistry, or modifications on its own. Pairing it with a persistent identifier like PubChem CID 9941957 gives anyone, anywhere, a way to verify the exact molecule being discussed, rather than relying on an informal trade code.

Anyone sourcing or documenting this peptide for lab work benefits from citing the sequence and CID together rather than a product name alone. Mycelia Link’s own BPC-157 research listing follows that same practice, pairing the sequence with its database reference.

Quick Reference: Do’s, Don’ts, and Common Mistakes

Keep a short mental checklist before submitting a sequence anywhere it will be read by another chemist or ingested into a database.

Do: write N-to-C, always. Use “-yl” endings correctly when constructing full names. Bracket replacements clearly, as in [Phe4]Peptide. Localize modifications with residue number plus atom locant. Attach a database ID whenever one exists.

Don’t: mix one-letter and three-letter codes in the same string. Omit terminal markers on a modified or charged peptide. Assume a circular sequence diagram counts as a valid cyclic name.

Pro Tip: Before sharing or publishing any sequence, attach three things together: the terminal-explicit notation, the ionization state if relevant, and a persistent database ID. That combination is what actually prevents someone three labs away from misreading your peptide.

Why Precise Peptide Naming Matters: A Mycelia Link Perspective

Ambiguous naming is how research gets wasted. Good peptide listings build around the IUPAC conventions covered here: full sequence notation, terminal-explicit forms, and a linked database identifier alongside a visible Certificate of Analysis. That pairing exists so a researcher can verify exactly what they’re ordering before it ships, not after. Questions about how a specific research peptide listing maps to its sequence and CID are always welcome. Naming precision is a transparency issue, not just a chemistry formality.

— Mycelia Link Industries

Sources

For manuscript naming and database deposition, work directly from the primary sources rather than secondhand summaries.

• Nomenclature and Symbolism for Amino Acids and Peptides (3AA-11 to 3AA-13)
• PubChem: BPC-157 (CID 9941957)
• Nomenclature of cyclic peptides (IUPAC recommendations, 2004)

FAQ

What Is the Sequence of BPC-157?

BPC-157’s sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, or GEPPPGKPADDAGLV in one-letter form. PubChem lists it under CID 9941957 with the terminal-explicit form H-GEPPPGKPADDAGLV-OH.

How Do You Label a Peptide Correctly?

Write the sequence from the N-terminus to the C-terminus using either one-letter or three-letter amino-acid codes, and include terminal markers (H- and -OH) when the ionization state matters. For publication or database deposition, pair the sequence with a persistent identifier like a PubChem CID, following the IUPAC/JCBN recommendations.

What Are the Main Categories of Peptides by Size?

IUPAC treats “peptide” as a broad category defined by amide bonds between amino acids, with oligopeptide and polypeptide used as approximate size labels rather than fixed cutoffs. Oligopeptides generally run under about 10 to 20 residues, polypeptides run longer, and the boundary where a chain gets called a protein is not formally fixed, according to IUPAC’s own definition.

What Do the Abbreviation Codes Like X, B, and Z Mean?

X (Xaa) marks an unspecified or unknown residue, B (Asx) signals ambiguity between aspartate and asparagine, and Z (Glx) signals ambiguity between glutamate and glutamine. U (Sec) denotes selenocysteine, the 21st amino acid, per the official IUPAC symbol tables.

Recommended

• Peptides
• BPC-157 — Transparency Series
• Peptide Wellness Research Examples: 2026 Guide
• BPC-157 — Research Offer